Last reviewed · How we verify
single dose misoprostol
At a glance
| Generic name | single dose misoprostol |
|---|---|
| Sponsor | Mansoura University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial (PHASE4)
- The Misoprostol-Only Regimen Evidence Study (PHASE4)
- Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section (NA)
- Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage (PHASE4)
- Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage (NA)
- Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
- Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy (EARLY_PHASE1)
- Sequential Use of Foley's Catheter and Misoprostol Versus Misoprostol Alone for Induction of Labour: a Multicentre Randomised Controlled Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |